title: Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.
authors.affiliation: From the *National Institute of Mental Health, NIH, Rockville, MD; †AstraZeneca Neuroscience Innovative Medicines Unit, Cambridge, MA; and ‡UCLA Semel Institute for Neurosciences, Los Angeles, CA.
authors.forename: Margaret C
authors.initials: MC
authors.lastname: Grabb
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Cross
authors.forename: William Z
authors.initials: WZ
authors.lastname: Potter
authors.forename: James T
authors.initials: JT
authors.lastname: McCracken
mesh_terms: D002986:Clinical Trials as Topic / Q000458:organization & administration*; D055808:Drug Discovery / Q000458:organization & administration*; D006801:Humans; D009315:National Institute of Mental Health (U.S.) / Q000458:organization & administration*; D011619:Psychotropic Drugs; D014481:United States
chemical_list: D011619:Psychotropic Drugs